BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27695017)

  • 1. Prognostic utility of biomarker growth differentiation factor- 15 in patients with acute decompensated heart failure.
    Jankovic-Tomasevic R; Pavlovic SU; Jevtovic-Stoimenov T; Apostolovic S; Stanojevic D; Jovanovic I; Koracevic G; Djordjevic-Radojkovic D; Damjanovic M; Salinger-Martinovic S; Pavlovic M
    Acta Cardiol; 2016; 71(5):587-595. PubMed ID: 27695017
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
    PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.
    Richter B; Koller L; Hohensinner PJ; Zorn G; Brekalo M; Berger R; Mörtl D; Maurer G; Pacher R; Huber K; Wojta J; Hülsmann M; Niessner A
    Int J Cardiol; 2013 Sep; 168(2):1251-7. PubMed ID: 23218577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA
    Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor-15 in heart failure.
    Kempf T; Wollert KC
    Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
    Schopfer DW; Ku IA; Regan M; Whooley MA
    Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis.
    Wang Y; Zhen C; Wang R; Wang G
    Am J Emerg Med; 2019 Jul; 37(7):1346-1352. PubMed ID: 31029521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-differentiation factor 15 as a predictor of mortality in patients with heart failure: a meta-analysis.
    Zeng X; Li L; Wen H; Bi Q
    J Cardiovasc Med (Hagerstown); 2017 Feb; 18(2):53-59. PubMed ID: 27454651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Osteoprotegerin in Acute Heart Failure.
    Friões F; Laszczynska O; Almeida PB; Silva N; Guimarães JT; Omland T; Azevedo A; Bettencourt P
    Can J Cardiol; 2015 Oct; 31(10):1266-71. PubMed ID: 26143141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF 15--A Novel Biomarker in the Offing for Heart Failure.
    George M; Jena A; Srivatsan V; Muthukumar R; Dhandapani VE
    Curr Cardiol Rev; 2016; 12(1):37-46. PubMed ID: 26750722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-differentiation factor-15 and major cardiac events.
    Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
    Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor 15 in different stages of heart failure: potential screening implications.
    Wang F; Guo Y; Yu H; Zheng L; Mi L; Gao W
    Biomarkers; 2010 Dec; 15(8):671-6. PubMed ID: 20860541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.